Second-Generation Jak2 Inhibitors for Advanced Prostate Cancer: Are We Ready for Clinical Development? is a research paper published in Cancers (2021). On theSindex it has a DataRank of 0.483. It has been cited 24 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.483
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →NCI NIH HHS
Grant: R01 CA212097
National Institutes of Health
Grant: 5R01CA249882-04
Prostate Cancer Radio-Pathomics for Differentiating Clinically Significant Disease
National Institutes of Health
Grant: 5KL2TR001438-04
Clinical and Translational Science Award
National Institutes of Health
Grant: 5R01CA212097-06
Cell free nucleic acid-based biomarkers in advanced prostate cancer
FWCI
1.63
Citation Percentile
0.8%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals